Mireca Medicines
Tübingen, DE · 1 known investors
Mireca Medicines is a preclinical-stage biopharmaceutical company developing proprietary cyclic guanosine monophosphate (cGMP)-analog drug products and drug delivery technologies for diseases caused by cGMP dysregulation affecting protein kinase G (PKG). Its lead program targets PKG inhibition for neuroprotection in inherited retinal diseases such as Retinitis Pigmentosa, Leber's Congenital Amaurosis, and Stargardt's disease.
BiotechMedical Devices
Investors · 1
Frequently asked questions
- What does Mireca Medicines do?
- Mireca Medicines is a preclinical-stage biopharmaceutical company developing proprietary cyclic guanosine monophosphate (cGMP)-analog drug products and drug delivery technologies for diseases caused by cGMP dysregulation affecting protein kinase G (PKG). Its lead program targets PKG inhibition for neuroprotection in inherited retinal diseases such as Retinitis Pigmentosa, Leber's Congenital Amaurosis, and Stargardt's disease.
- Who are Mireca Medicines's investors?
- Mireca Medicines's investors include LU Innovation.
- Where is Mireca Medicines headquartered?
- Mireca Medicines is headquartered in Tübingen, DE.